产品

本公司产品仅供体外研究使用,不用于临床诊断

USP28 antibody

分类: 研究方向:
别称:Deubiquitinating enzyme 28 antibody, KIAA1515 antibody, Ubiquitin thiolesterase 28 antibody, USP28 antibody
货号:FNab09322反应性:Human, Mouse, Rat
宿主:Rabbit验证实验:ELISA, WB, IHC, IP
克隆性:polyclonal亚型:IgG
¥1900
规格:
货期: 三个工作日+顺丰快递时长
  • 产品介绍
产品名称
USP28 antibody
货号
FNab09322
规格
100μg
状态
liquid
纯化方法
Immunogen affinity purified
纯度
≥95% as determined by SDS-PAGE
克隆性
polyclonal
亚型
IgG
存储
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
免疫原信息
免疫原
ubiquitin specific peptidase 28
别称
Deubiquitinating enzyme 28 antibody, KIAA1515 antibody, Ubiquitin thiolesterase 28 antibody, USP28 antibody
UniProt ID
Q96RU2
分子量
130 kDa
验证实验
验证实验
ELISA, WB, IHC, IP
建议稀释比例
WB: 1:500-1:5000; IP: 1:200-1:2000; IHC: 1:20-1:200
验证图片
HeLa cells were subjected to SDS PAGE followed by western blot with FNab09322(USP28 antibody) at dilution of 1:1000
IP Result of anti-USP28 (IP:FNab09322, 4ug; Detection:FNab09322 1:600) with HeLa cells lysate 2800ug.
Immunohistochemistry of paraffin-embedded human breast cancer using FNab09322(USP28 antibody) at dilution of 1:50
背景介绍
Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome(APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7(FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7(FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes(TSGs) in a subset of colorectal cancers(CRC) cells(PubMed:24623306).